Cardiol Therapeutics Inc. (CRDL) Financials
CRDL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 31.7 million | 6.0 million |
2023-06-30 | 35.6 million | 6.4 million |
2023-03-31 | 38.9 million | 5.3 million |
2022-12-31 | 45.7 million | 7.2 million |
CRDL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.5 million | 1.5 million |
2023-06-30 | -4.0 million | 503398 |
2023-03-31 | -7.4 million | 315484 |
2022-12-31 | -6.6 million | 699078 |
CRDL Net Income
No data available :(
CRDL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 29.8 million | - | 133332 |
2023-06-30 | 33.9 million | - | 36405 |
2023-03-31 | 36.6 million | - | 44838 |
2022-12-31 | 43.9 million | - | 53739 |
CRDL Shares Outstanding
CRDL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 4103 | 1.9 million | 3.7 million | - |
2023-06-30 | 2939 | 2.6 million | 2.1 million | - |
2023-03-31 | 32624 | 3.1 million | 2.7 million | - |
2022-12-31 | 35272 | 4.1 million | 2.6 million | - |
CRDL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 47748 |
2023-06-30 | - | 44187 |
2023-03-31 | - | 43022 |
2022-12-31 | - | 42797 |
CRDL
Price: $1.98
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -3.37
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 88200
Market Capitalization: 125.4 million